Martin Schiller In The News

Las Vegas Review Journal
In an old ad campaign, Gatorade asked athletes, "Is it in you?"
R & D Magazine
With millions of people infected with the HIV virus world-wide, a cure has yet to be found. The reason why vaccines and drugs are so hard to develop for this virus relates to both mutation and latency of the virus.
Las Vegas Review Journal
A collection of biological codes sits in a library at UNLV. Much of the focus is learning how the codes can help cells fight off HIV. Researchers hope this work can be used to develop drugs much faster.
Las Vegas Business Journal
Needles, pills and patches may become tools of the past for some medications, including those used for oral pain medications, nail fungus and possibly diabetes.
K.N.P.R. News
What would you do if there was a way to determine - with almost near certainty - what you might die from? Would you want to know? Would you want your doctor to know? Would you want your kids to know?
Associated Press
Seeded with a $2.5 million grant from the Nevada Governor’s Office of Economic Development and matching funds from UNLV, the institute will decode people’s genomes to predict individual susceptibility to disease, study treatment options and fine-tune drug dosages to minimize adverse effects, Executive Director Martin Schiller said.
Las Vegas Weekly
Looking at a graph of human life expectancy over the past four millennia, you get how far medicine has come from diagnosing witchcraft and prescribing bloodletting. But it’s still so inexact that for every year we live, we gain about two months of life. That’s how fast research is improving health care, says Martin Schiller, adding: “It’s maybe the best buy in history for return on investment.”
Las Vegas Sun
One of the most powerful computers in the world is on its way to being connected to UNLV.